US FDA Staff Questions Cell Therapeutics, Inc. Lymphoma Drug Pixantrone Data

Reuters -- U.S. drug reviewers questioned effectiveness data from Cell Therapeutics Inc (CTIC.O) for an experimental lymphoma drug and said the medicine carried substantial side effects, according to documents released on Monday.